Skip to content

Fake online pharmacies US Congressional briefing, Thursday June 23, 2011

Many “online pharmacies” are not pharmacies at all – they are large criminal organizations that make money by selling fake drugs with little or no active ingredient.  They are widely advertised through email spam and have convincing sounding names like “Trusted Pharmacy Co, UK.”  But they are not real pharmacies accredited by the National Association of Boards of Pharmacy, nor their products regulated by the FDA.  These criminal enterprises usually reside in countries with little ability to enforce fraud and counterfeiting laws.

To provide insights into this important public health matter, the Partnership for Safe Medicines and Senator Chris Coons hosted a briefing for members of Congress and their staff at the US Capitol Visitors Center.  You can watch the briefing below by pressing play, or watching it on YouTube.

Many “online pharmacies” are not pharmacies at all – they are large criminal organizations that make money by selling fake drugs with little or no active ingredient.  They are widely advertised through email spam and have convincing sounding names like “Trusted Pharmacy Co, UK.”  But they are not real pharmacies accredited by the National Association of Boards of Pharmacy, nor their products regulated by the FDA.  These criminal enterprises usually reside in countries with little ability to enforce fraud and counterfeiting laws.

To provide insights into this important public health matter, the Partnership for Safe Medicines and Senator Chris Coons hosted a briefing for members of Congress and their staff at the US Capitol Visitors Center.  You can watch the briefing below by pressing play, or watching it on YouTube.

 

  • Bryan Liang, MD, PhD, JD, Vice President of the Partnership for Safe Medicines; E. Donald Shapiro Distinguished Professor Executive Director, Institute of Health Law Studies, California Western School of Law; Professor of Anesthesiology, Director, San Diego Center for Patient Safety, University of California San Diego School of Medicine  [See Bryan’s slides]
  • Melissa Madigan, PharmD, JD, Policy and Communications Director, National Association of Boards of Pharmacy [See Melissa’s slides]
  • Ilisa Bernstein, PharmD, JD, Deputy Director, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration [See Ilisa’s slides]

See our flickr photo set:

www.flickr.com

SafeMedicines' June 23 Congressional Briefing photoset SafeMedicines’ June 23 Congressional Briefing photoset

Scroll To Top